SCHEMBL4886181

SCHEMBL4886181

C[C@H]1CNCC[C@H]1c1ccc2c(c1)CCO2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.36
DYRK1A Q13627 2/20 0.36
PIK3CA P42336 1/20 0.36
DYRK2 Q92630 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
DRD2 P14416 2/20 0.36
DRD3 P35462 2/20 0.36
KDM1A O60341 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
CYP3A4 P08684 4/20 0.34
SLC6A4 P31645 2/20 0.34
TP53 P04637 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2D6 P10635 2/20 0.34
GRK2 P25098 2/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP2C9 P11712 1/20 0.34
HSD17B10 Q99714 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4886195 1.00 PRKCI (0.36) PRKCIDYRK1APIK3CADYRK2DYRK1B
SCHEMBL4886190 1.00 PRKCI (0.36) PRKCIDYRK1APIK3CADYRK2DYRK1B
SCHEMBL17032981 0.79 KDM1A (0.44) PRKCIDYRK1APIK3CADYRK2DYRK1B
SCHEMBL4890839 0.77 HTR3A (0.36) SLC6A4HTR1AADRA2CCNR1SLC6A2
SCHEMBL4890857 0.77 HTR3A (0.36) SLC6A4HTR1AADRA2CCNR1SLC6A2
SCHEMBL4890845 0.77 HTR3A (0.36) SLC6A4HTR1AADRA2CCNR1SLC6A2
SCHEMBL2711041 0.77 QDPR (0.47) PRKCIDYRK1APIK3CAHTR6SIGMAR1
SCHEMBL18590462 0.73 PDE4A (0.56) PRKCIDYRK1APIK3CADYRK2DYRK1B
SCHEMBL26513787 0.72 HTR2C (0.41) HTR2AHTR2BP2RY14
SCHEMBL25320358 0.71 L3MBTL1 (0.43) PRKCIDYRK1APIK3CADYRK2DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312271-A1 AZABENZIMIDAZOLYL COMPOUNDS PFIZER INC. 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312271-A1 AZABENZIMIDAZOLYL COMPOUNDS AZI2, PAICS, UGT2B7 PRKCI 3224/4885DYRK1A 3653/4885PIK3CA 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.